Prilosec OTC Soothes P&G First Quarter Forecast As Early Shipments Rollout
This article was originally published in The Tan Sheet
Stronger than expected initial orders for Prilosec OTC are responsible in part for Procter & Gamble's increase in its first quarter earnings guidance for fiscal year 2004
You may also be interested in...
Galpharm Healthcare will launch a nonprescription omeprazole product under the name Galpharm Heartburn Relief in the UK "shortly," according to a spokesperson for the British firm
Ad claims for Pfizer's Zantac 75 that compare the H2 antagonist to Procter & Gamble's Prilosec OTC should be modified so consumers understand the heartburn remedies have different indications, the National Advertising Division of the Council for Better Business Bureaus concludes following a recent inquiry
Procter & Gamble is addressing shortfalls in its supply chain in order to meet higher than expected customer demand for Prilosec OTC